These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12596751)

  • 21. ACE inhibitors and ARBs: antihypertensive medications in CKD.
    Szromba C
    Nephrol Nurs J; 2005; 32(3):332-3. PubMed ID: 16035474
    [No Abstract]   [Full Text] [Related]  

  • 22. Proteinuria as a therapeutic target in patients with chronic kidney disease.
    Palmer BF
    Am J Nephrol; 2007; 27(3):287-93. PubMed ID: 17457028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward better renoprotection: lessons from angiotensin receptor blockers.
    Miyata T; Takizawa S
    Hemodial Int; 2007 Apr; 11(2):164-8. PubMed ID: 17403166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diuretics are preferred over angiotensin II-converting enzyme inhibitors for initial therapy of uncomplicated hypertension.
    Grimm R
    Am J Kidney Dis; 2007 Aug; 50(2):188-96. PubMed ID: 17660020
    [No Abstract]   [Full Text] [Related]  

  • 25. How should renin-angiotensin system blockade be applied in chronic kidney disease for optimal renal protection?
    Zhang X; Hou FF
    Chin Med J (Engl); 2007 Feb; 120(3):243-5. PubMed ID: 17355830
    [No Abstract]   [Full Text] [Related]  

  • 26. [ACE-inhibitors in renal protection].
    Barna I
    Orv Hetil; 2006 Jun; 147(22):1019-23. PubMed ID: 16913091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
    Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
    Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, or both in chronic heart failure.
    Young JB
    Heart Fail Clin; 2005 Apr; 1(1):39-47. PubMed ID: 17386832
    [No Abstract]   [Full Text] [Related]  

  • 29. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Ferrari P
    Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The OPTIMAAL study, not so optimal: the lessons of LIFE, RENAAL and IDNT.
    Lapointe N; Pourdjabbar A; Rouleau JL
    Can J Cardiol; 2003 Aug; 19(9):994-6. PubMed ID: 12915925
    [No Abstract]   [Full Text] [Related]  

  • 31. [High risk arterial hypertension: the role of angiotensin II receptor blockers].
    Fomin VV; Moiseev SV; Mukhin NA
    Ter Arkh; 2007; 79(10):86-91. PubMed ID: 18154154
    [No Abstract]   [Full Text] [Related]  

  • 32. Is proteinuria reduction by angiotensin-converting enzyme inhibition enough to prove its role in renal protection in IgA nephropathy?
    Cattran DC
    J Am Soc Nephrol; 2007 Jun; 18(6):1633-4. PubMed ID: 17494880
    [No Abstract]   [Full Text] [Related]  

  • 33. [Renoprotective effects of antihypertensives].
    Monhart V
    Vnitr Lek; 2004 Jul; 50(7):531-6. PubMed ID: 15323261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facility variation in utilization of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and chronic kidney disease.
    Tiwari A; Tseng CL; Kern EF; Maney M; Miller DR; Pogach L
    Am J Manag Care; 2007 Feb; 13(2):73-9. PubMed ID: 17286527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
    Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
    Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
    Matsuda H; Hayashi K; Saruta T
    J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Standpoint on the use of angiotensin receptor blockers in the treatment of hypertension].
    Stern N; Grossman E; ; ; ;
    Harefuah; 2003 Apr; 142(4):309-11, 315. PubMed ID: 12754885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M; Ménard J
    Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract]   [Full Text] [Related]  

  • 39. [IgA nephropathy].
    Alamartine E
    Rev Prat; 2003 Nov; 53(18):2023-6. PubMed ID: 15008216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria.
    Rodicio JL; Alcazar JM; Ruilope LM
    Kidney Int; 1990 Oct; 38(4):590-4. PubMed ID: 2232500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.